Sahil Kirpekar - 14 Mar 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Chief Business Officer
Signature: /s/ Ryan Barrett, Attorney-in-fact
Issuer symbol: ATAI
Transactions as of: 14 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 19 Mar 2025, 19:29:45 UTC
Previous filing: 04 Apr 2024
Next filing: 24 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Options Exercise		+100K	+155.77%		164K	14 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATAI	Common Shares	Options Exercise		-100K	-100%		0	14 Mar 2025	Common Shares	100K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date, and 50% vested on March 14, 2025, the second anniversary of the grant date.